Skip to content
10-K

Annual Report

BioLife Solutions, Inc. BLFS

0001628280-26-012294

← back to feed
Filed
Feb 26, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 19, 2026 48.3M sh
Shares Diluted FY 2025 · Dec 31, 2025 48.65M sh
Shares Diluted FY 2025 · Dec 31, 2024 46.07M sh
Shares Diluted FY 2025 · Dec 31, 2023 43.72M sh
Capex FY 2025 · Dec 31, 2025 $9.48M
Capex FY 2025 · Dec 31, 2024 $3.23M
Capex FY 2025 · Dec 31, 2023 $6.38M
Operating Cash Flow FY 2025 · Dec 31, 2025 $20.12M
Operating Cash Flow FY 2025 · Dec 31, 2024 $8.43M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$12.5M
Long Term Debt FY 2025 · Dec 31, 2025 $0
Long Term Debt FY 2025 · Dec 31, 2024 $5M
Short Term Debt FY 2025 · Dec 31, 2025 $5M
Short Term Debt FY 2025 · Dec 31, 2024 $10.94M
Cash And Equivalents FY 2025 · Dec 31, 2025 $33.04M
Cash And Equivalents restated FY 2025 · Dec 31, 2024 $91.54M
Stockholders Equity FY 2025 · Dec 31, 2025 $371.89M
Stockholders Equity FY 2025 · Dec 31, 2024 $348.91M
Stockholders Equity FY 2025 · Dec 31, 2023 $337.66M
Stockholders Equity FY 2025 · Dec 31, 2022 $364.19M
Current Liabilities FY 2025 · Dec 31, 2025 $22.98M
Current Liabilities FY 2025 · Dec 31, 2024 $32.73M
Total Liabilities FY 2025 · Dec 31, 2025 $34M
Total Liabilities FY 2025 · Dec 31, 2024 $50.58M
Current Assets FY 2025 · Dec 31, 2025 $136.56M
Current Assets FY 2025 · Dec 31, 2024 $148.76M
Total Assets FY 2025 · Dec 31, 2025 $405.88M
Total Assets FY 2025 · Dec 31, 2024 $399.49M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.10
Eps Diluted FY 2025 · Dec 31, 2024 −$0.44
Eps Diluted restated FY 2025 · Dec 31, 2023 −$1.55
Eps Basic FY 2025 · Dec 31, 2025 −$0.09
Eps Basic FY 2025 · Dec 31, 2024 −$0.44
Eps Basic restated FY 2025 · Dec 31, 2023 −$1.55
Sga Expense FY 2025 · Dec 31, 2025 $45.52M
Sga Expense restated FY 2025 · Dec 31, 2024 $40.63M
Sga Expense restated FY 2025 · Dec 31, 2023 $42.79M
Rd Expense FY 2025 · Dec 31, 2025 $7.57M
Rd Expense restated FY 2025 · Dec 31, 2024 $4.75M
Rd Expense restated FY 2025 · Dec 31, 2023 $5.52M
Net Income FY 2025 · Dec 31, 2025 −$4.6M
Net Income FY 2025 · Dec 31, 2024 −$20.18M
Net Income restated FY 2025 · Dec 31, 2023 −$68M
Operating Income FY 2025 · Dec 31, 2025 −$16.6M
Operating Income restated FY 2025 · Dec 31, 2024 −$4.48M
Operating Income restated FY 2025 · Dec 31, 2023 −$17.21M
Gross Profit FY 2025 · Dec 31, 2025 $62.12M
Gross Profit FY 2025 · Dec 31, 2024 $50.1M
Gross Profit FY 2025 · Dec 31, 2023 $41.32M
Cost Of Revenue FY 2025 · Dec 31, 2025 $34.1M
Cost Of Revenue FY 2025 · Dec 31, 2024 $24.55M
Cost Of Revenue FY 2025 · Dec 31, 2023 $26.7M